Camurus AB selected the best private biotech company in Medicon Valley 2007

Tuesdag evening Camurus AB won the award as the best private biotech company in Medicon Valley at the Strictly Financing Award 2007. Camurus won as the best out of six biotech companies from Denmark and Sweden that competed for six British investors' favour and money.

Six nomineed biotech companies from Denmark and Sweden had each 15 minutes to convince a panel of six British investors that precisely their company is the best private biotech company in Medicon Valley. The Swedish biotech company Camurus from Lund came out as the winner.

- We are delighted and honoured with the award. This day has proved that Danish and Swedish biotech represents very solid and strong companies. The award is a recognition of our potential to stay successful and expand and with that we are pleased, said Fredrik Tiberg, President and CEO, Camurus.

A high standard in Medicon Valley

In the panel of judges it was agreed that Danish-Swedish biotech puts on an impressive performance.

- The standard of the six companies was very high and it was a close race. We went for Camurus, partly because they demonstrated a carefully prepared and cost-effective strategy, said Patrick Lee from the British investor Advent Venture Partners on behalf of the panel of judges.

The Audience Award

The audience did too participate in the selection and came up with their vote for a supplemental award, the Audience Award. This award went to Egalet from Denmark.

The other nomineed was Astion Pharma, NatImmune, Santaris Pharma and Symphogen.

For further information, read the MVA press release 12.06.2007 (in English).

For further information, read the MVA press release 12.06.2007 (in Danish).

Or visit the Strictly Financing Award 2007 homepage. 

Read more about the succesfull biotech industry in Medicon Valley in the article from www.business.dk on 12 June 2007: "Spectacular growth in pharma and biotech shares" (in Danish)

Source: Medicon Valley Academy, 12.06.2007